Activation of cAMP-PKA signaling in vivo inhibits smooth muscle cell proliferation induced by vascular injury

Nature Medicine

Volumn 3, Issue 7, 1997, Pages 775-781

  Indolfi, Ciro ^a   Avvedimento, Enrico Vittorio ^b   Di Lorenzo, Emilio ^a   Esposito, Giovanni ^a   Rapacciuolo, Antonio ^a   Giuliano, Paola ^a   Grieco, Domenico ^a   Cavuto, Luigi ^a   Stingone, Angela M ^a   Ciullo, Ilaria ^a   Condorelli, Gianluigi ^c   Chiariello, Massimo ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b Facolta di Medicina   (Italy)

^c THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE;

ANIMAL CELL; ARTERY INTIMA PROLIFERATION; ARTICLE; ATHEROSCLEROSIS; BLOOD VESSEL INJURY; CELL PROLIFERATION; INTIMA; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RAT; VASCULAR SMOOTH MUSCLE;

8-BROMO CYCLIC ADENOSINE MONOPHOSPHATE; AMINOPHYLLINE; AMRINONE; ANIMALS; CAROTID ARTERIES; CELL DIVISION; CELLS, CULTURED; CYCLIC AMP-DEPENDENT PROTEIN KINASES; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME ACTIVATION; GROWTH INHIBITORS; MUSCLE, SMOOTH, VASCULAR; PHOSPHODIESTERASE INHIBITORS; RATS; SIGNAL TRANSDUCTION;

ADENOVIRIDAE; ANIMALIA;

EID: 0030835725     PISSN: 10788956     EISSN: None     Source Type: Journal    
DOI: 10.1038/nm0797-775     Document Type: Article

References (42)

1. Schwartz, S.M., Heimark, R.L. & Majesky, M.W. Developmental mechanisms underlying pathology of arteries. Physiol. Rev. 70, 1177-1209 (1990).
2. Ross, R. The pathogenesis of atherosclerosis: A perspective for 1990. Nature 362, 801-809 (1993).
3. Virmani, R., Farb, A. & Burke, A.P. Coronary angioplasty from the prospective of atherosclerotic plaque: Morphologic predictors of immediate success and restenosis. Am. Heart J. 127, 163-179 (1994).
4. Clowes, A.W., Reidy, M.A. & Clowes, M.M. Mechanisms of stenosis after arterial injury. Lab. Invest. 49, 208-215 (1983).
5. Clowes, A.W., Reidy, M.A. & Clowes, M.M. Kinetics of cellular proliferation after arterial injury. I. Smooth muscle growth in the absence of endothelium. Lab. Invest. 49, 327-333 (1983).
6. Edelman, E.R., Nugent, M.A., Smith, L.T. & Karnovsky, M.J. Basic fibroblast growth factor enhances the coupling of intimal hyperplasia and proliferation of vasa vasorum in injured rat arteries. J. Clin. Invest. 89, 465-473 (1992).
7. Jawien, A., Bowen-Pope, D.F., Lindner, V., Schwartz, S.M. & Clowes, A.W. Platelet-derived growth factor promotes smooth muscle migration and intimal thickening in a rat model of balloon angioplasty. J. Clin. Invest. 89, 507-511 (1992).
8. Indolfi, C. et al. Inhibition of cellular ras prevents smooth muscle cell proliferation after vascular injury in vivo. Nature Med. 1, 541-545 (1995).
9. Indolfi, C., Chiariello, M. & Avvedimento, E.V. Selective gene therapy for proliferative disorders: Sense and antisense. Nature Med. 2, 634-635 (1996).
10. Chang, M.V. et al. Adenovirus-mediated transfer of the herpes simplex virus thymidine kinase inhibits vascular smooth muscle cell proliferation and neointima formation following balloon angioplasty of the rat carotid artery. Mol. Med. 1, 172-181 (1995).
11. Chang, M.V. et al. Cytostatic gene therapy for vascular proliferative disorder with a constitutively active form of the retinoblastoma gene product. Science 267, 518-522 (1995).
12. Simons, M., Edelman, E.R., DeKeyser, J.L., Langer, R. & Rosenberg, R.D. Antisense c-myb oligonucleotides inhibit intimal arterial smooth muscle cell accumulation in vivo. Nature 359, 67-70 (1992).
13. ++ mobilization, by cyclic AMP and GMP in rabbit aortic smooth muscle cells. Biochem. J. 288, 527-532 (1992).
14. Boynton, A.L. & Whitfield, J.F. The role of cAMP in cell proliferation: A critical assessment of the evidence. Adv. Cyclic Nucleotide Res. 15, 193-294 (1983).
15. Cornwell, T.L., Arnold, E., Boerth, N.J. & Lincoln, T.M. Inhibition of smooth muscle cell growth by nitric oxide and activation of cAMP-dependent protein kinase by cGMP. Am. J. Physiol. 36, 1405-1413 (1994).
16. Yokozaki, H. et al. Unhydrolyzable analogues of adenosine 3′:5′-monophosphate demonstrating growth inhibition and differentiation in human cancer cells. Cancer Res. 52, 2504-2508 (1992).
17. Skalhegg, B.S. et al. Cyclic AMP-dependent protein kinase type I mediates the inhibitory effects of 3′ 5′ -cyclic adenosine monophosphate on cell replication in human T lymphocytes. J. Biol. Chem. 267, 15707-15714 (1992).
18. Sutherland, E.W. Studies on the mechanism of hormone action. Science 177, 401-408 (1972).
19. Schwartz, D.A. & Rubin, C.S. Regulation of cAMP-dependent protein kinase sub-unit levels in friend erythroleukemic cells. J. Biol. Chem. 258, 777-784 (1983).
20. Pastan, I.H., Johnson, G.S. & Anderson, W.B. Role of cyclic nucleotides in growth control. Annu. Rev. Biochem. 44, 491-522 (1975).
21. Mitsuzawa, H. Increases in cell size at START caused by hyperactivation of the cAMP pathway in Saccharomyces cerevisae. Mol. Gen. Genet. 243, 158-165 (1994).
22. Goodman & Gilman's The Pharmacological Basis of Therapeutics. (McGraw-Hill, NewYork, 1995).
23. Indolfi, C. et al. Smooth muscle cell proliferation is proportional to the degree of balloon injury in a rat model of angioplasty. Circulation 92, 1230-1235 (1995).
24. Powell, J.S. et al. Inhibition of angiotensin-converting enzyme prevent myointimal proliferation after vascular injury. Science 245, 186-188 (1989).
25. Grieco, D., Porcellini, A., Avvedimento, E.V. & Gottesman, M.E. Requirement for cAMP-PKA pathway activation by M-phase-promoting factor in the transition from mitosis to interphase. Science 271, 1718-1723 (1996).
26. Bokar, J.A. et al. Characterization of the cAMP responsive elements from the genes for the alpha-subunit of glycoprotein hormones and phosphoenolpyruvate carboxykinase (GTP): Conserved features of nuclear protein binding between tissues and species. J. Biol. Chem. 263, 19740-19747 (1988).
27. Krebs, E.G. & Beavo, J.A. Phosphorylation-dephosphorylation of enzymes. Annu. Rev. Biochem. 48, 923-959 (1979).
28. Stryer, L. & Bourne, H.R. G proteins: a family of signal transducers [Review]. Annu.. Rev. Cell. Biol. 2, 391-419 (1986).
29. Choi, E.J., Xia, Z., Villacres, E.C. & Storm, D.R. The regulatory diversity of the mammalian adenyl cyclases [Review]. Curr. Opin. Cell Biol. 5, 269-273 (1993).
30. Cook, S. J. & McCormick, F. Inhibition by cAMP of Ras-dependent activation of Raf. Science 262, 1069-1072 (1993).
31. Holmes, D.R., Jr., et al. Restenosis after percutaneous transluminal coronary angioplasty: A report from the PTCA registry of the National Heart, Lung, and Blood Institute. Am. J. Cardiol. 53, 77C-81C (1984).
32. McBride, W. et al. Restenosis after successful coronary angioplasty. N. Engl. J. Med. 318, 1734-1737 (1988).
33. Leimgruber, P.P. et al. Restenosis after successful coronary angioplasty in patients with single-vessel disease. Circulation 73, 710-717 (1986).
34. Guiteras Va, P. et al. Restenosis after successful percutaneous transluminal coronary angioplasty: The Montreal Heart Institute experience. Am. J. Cardiol. 60 (Suppl.), 50B-55B (1987).
35. The Multicenter European Research Trial with Cilazapril after Angioplasty to Prevent Transluminal Coronary Obstruction and Restenosis (MERCATOR) Study Group. Does the new angiotensin converting enzyme inhibitor cilazapril prevent restenosis after percutaneous transluminal coronary angioplasty? Results of the MERCATOR study: A multicenter, randomized, double-blind placebo-controlled trial. Circulation 86, 100-110 (1991).
36. Herrmann, J.P., Hermans, W.R., Vos, J. & Serruys, P.W. Pharmacological approaches to the prevention of restenosis following angioplasty: The search for the Holy Grail? Drugs 46, 249-262 (1993).
37. Laird, J.R. et al. Inhibition of neointimal proliferation with low-dose irradiation from a β-particle-emitting stent. Circulation 93, 529-536 (1996).
38. Serruys, P.W. et al. Heparin-coated Palmaz-Schatz stents in human coronary arteries. Circulation 93, 412-422 (1996).
39. Nunes, G.L. et al., Inhibition of platelet-dependent thrombosis by local delivery of heparin with a hydrogel-coated balloon. Circulation 92, 1697-1700 (1995).
40. Rothman, A. et al. Development and characterization of a cloned rat pulmonary arterial smooth muscle cell line that maintains differentiated properties through multiple subcultures. Circulation 86, 1977-1986 (1992).
41. Wilkinson, L. SYSTAT, the System for Statistics. (SYSTAT, Inc., Evanston, IL, 1988).
42. Koumi, S., Backer, C.L., Arentzen, C.E. & Sato, R. Beta adrenergic modulation of the inwardly rectifying potassium channel in isolated human ventricular myocytes: Alteration in channel response to beta adrenergic stimulation in failing human hearts. J. Clin. Invest. 96, 2870-2881 (1995).